Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...
Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And ...
In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...
Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.
Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ...
People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...
Rise in prevalence of cardiovascular disease and rise in demand for pain management solutions are major factors that drive the growth of the global aspirin drugs market. However, availability of ...
Aspirin and COX-1 inhibitors boost immunity against cancer metastasis, revealing a new pathway for anti-metastatic therapies.
WILMINGTON, Del., March 24, 2025 /PRNewswire/ -- Allied Market Research published a report, titled, "Aspirin Drugs Market by Dosage Form (Tablets, Capsules, and Others), Application (Pain ...